Iradimed designs MRI-compatible patient care devices, notably non-magnetic IV infusion pumps and vital-signs monitors that can operate safely inside the MRI suite. Conventional pumps and monitors contain ferromagnetic parts and cannot stay with the patient during scanning, so specialized equipment fills a narrow hospital niche. Customers are hospitals and imaging centers that need continuous drug delivery and monitoring during magnetic resonance procedures.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 20.4 | — | 5.8 | 8.6% |
| Q3 2025 | 21.2 | — | 5.6 | 2.4% |
| Q4 2025 | 22.7 | — | 6.4 | 27.1% |
| Q1 2026 | 22 | — | 5.8 | 8.9% |
| Q2 2026 | 20.5 | 0.3% | 5.2 | -9.6% |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Iambic Therapeutics, Inc. (IAM), Heritage Financial Corporation (HFWA), Gibraltar Industries, Inc. (ROCK), VNET Group, Inc. (VNET), CRA International, Inc. (CRAI), Bicara Therapeutics Inc. (BCAX)